Antitumor effects of bisphosphonates
- 23 January 2003
- Vol. 97 (S3), 840-847
- https://doi.org/10.1002/cncr.11128
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Early Detection of Bone Metastases in a Murine Model Using Fluorescent Human Breast Cancer Cells: Application to the Use of the Bisphosphonate Zoledronic Acid in the Treatment of Osteolytic LesionsJournal of Bone and Mineral Research, 2001
- Osteolysis and cancerJCI Insight, 2001
- The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myelomaBritish Journal of Haematology, 2000
- Pamidronate in acquired immune deficiency syndromeBone, 1999
- Changes in Bone Turnover Markers and Menstrual Function After Short-term Oral DHEA in Young Women with Anorexia NervosaJournal of Bone and Mineral Research, 1999
- Inhibition of antigen-presenting cell function by alendronate in vitroJournal of Bone and Mineral Research, 1995
- Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model systemJournal of Bone and Mineral Research, 1994
- Effect of etidronate disodium on the development of bone lesions in an animal model of bone metastasis using the human prostate cancer cell line PC‐3The Prostate, 1991
- Protective Effects of a Prophylactic Treatment with the Bisphosphonate 3-Amino-1 -Hydroxypropane-1,1 -Bisphosphonic Acid on the Development of Tumor Osteopathies in the Rat: Experimental Studies with the Walker Carcinosarcoma 256Oncology, 1988
- The beneficial effects of diphosphonate and piroxicam on the osteolytic and metastatic spread of rat prostate carcinoma cellsThe Prostate, 1986